An injectable alginate/extra cellular matrix (ECM) hydrogel towards acellular treatment of heart failure
Authors:
Open Access
- 3 December 2018
- journal article
- research article
- Published by Springer Nature in Drug Delivery and Translational Research
- Vol. 9 (1) , 1-13
Abstract
As treatments for myocardial infarction (MI) continue to improve, the population of people suffering from heart failure (HF) is rising significantly. Novel treatment strategies aimed at achieving long-term functional stabilisation and improvement in heart function post MI include the delivery of biomaterial hydrogels and myocardial matrix-based therapies to the left ventricle wall. Individually alginate hydrogels and myocardial matrix-based therapies are at the most advanced stages of commercial/clinical development for this potential treatment option. However, despite these individual successes, the potential synergistic effect gained by combining the two therapies remains unexplored. This study serves as a translational step in evaluating the minimally invasive delivery of dual acting alginate-based hydrogels to the heart. We have successfully developed new production methods for hybrid alginate/extracellular matrix (ECM) hydrogels. We have identified that the high G block alginate/ECM hybrid hydrogel has appropriate rheological and mechanical properties (1.6 KPa storage modulus, 29 KPa compressive modulus and 14 KPa dynamic modulus at day 1) and can be delivered using a minimally invasive delivery device. Furthermore, we have determined that these novel hydrogels are not cytotoxic and are capable of enhancing the metabolic activity of dermal fibroblasts in vitro (p < 0.01). Overall these results suggest that an effective minimally invasive HF treatment option could be achieved by combining alginate and ECM particles.Keywords
This publication has 47 references indexed in Scilit:
- Catheter-Deliverable Hydrogel Derived From Decellularized Ventricular Extracellular Matrix Increases Endogenous Cardiomyocytes and Preserves Cardiac Function Post-Myocardial InfarctionJACC, 2012
- Alginate: Properties and biomedical applicationsProgress in Polymer Science, 2012
- Tailoring material properties of a nanofibrous extracellular matrix derived hydrogelNanotechnology, 2011
- Increased Infarct Wall Thickness by a Bio-Inert Material Is Insufficient to Prevent Negative Left Ventricular Remodeling after Myocardial InfarctionPLOS ONE, 2011
- Modulation of Material Properties of a Decellularized Myocardial Matrix ScaffoldMacromolecular Bioscience, 2011
- Intra-myocardial biomaterial injection therapy in the treatment of heart failure: Materials, outcomes and challengesActa Biomaterialia, 2011
- Injectable hydrogel properties influence infarct expansion and extent of postinfarction left ventricular remodeling in an ovine modelProceedings of the National Academy of Sciences, 2010
- Preparation of Cardiac Extracellular Matrix from an Intact Porcine HeartTissue Engineering Part C: Methods, 2009
- Ethical challenges with the left ventricular assist device as a destination therapyPhilosophy, Ethics, and Humanities in Medicine, 2008
- Trends in Heart Failure Incidence and Survival in a Community-Based PopulationJAMA, 2004